NAD+ precursors like NMN and NR are everywhere right now. Most supplement brands stick with capsules or powders because they're easy to manufacture. But consumers keep asking for gummies. They're convenient, they taste good, and they fit into a daily routine without hassle.
Making a stable, accurately dosed NAD+ gummy is hard work. It separates serious manufacturers from everyone else.
Three Problems You Don't See on the Label
Heat destroys the active ingredient
NAD+ precursors break down under heat. Standard gummy production heats the base to 70-90°C and holds it there while the batch is mixed and deposited. The hotter and longer the cook, the more precursor degrades, and the byproducts also shift the taste and color of the finished gummy.
The fix: Add the precursor after cooking, during final cooling below 40°C. KorNutra uses a staged heat gradient process that preserves over 95% structural integrity. Most gummy lines can't handle this step.
That bitter taste gets worse over time
NAD+ precursors have a natural metallic bitterness. The standard approach is to drown it in sugar and acid. But acids accelerate degradation of the nucleotide bond, which shortens shelf life. You end up trading taste for stability.
KorNutra's approach: A buffered gummy base with pH between 5.0 and 5.5, plus microencapsulation of the precursor in a neutral lipid shell. No artificial sweeteners, no chemical aftertaste. Clean flavor that stays clean for 24 months.
Dose uniformity is a real headache
In capsules, you weigh each one and call it done. In gummies, the heavy precursor powder settles in the thick mass. One gummy might get 80mg, the next 120mg. That variance matters when the label promises a specific dose per piece.
Our solution: Continuous inline homogenization keeps the precursor evenly suspended until the moment each gummy is deposited. Then every single gummy gets checked by NIR spectroscopy to confirm potency within ±2%. That level of checking is rare in this industry, but it's non-negotiable for a product like this.
The Dose Ceiling and the Cost of Overage
A finished gummy weighs only a few grams, and most of that mass is sweetener, pectin or gelatin, and water. Only so much precursor fits in one piece before the texture turns chalky and the bitterness overwhelms the flavor system. A dose that works in one capsule often means two or three gummies per serving.
The cost compounds the problem. Because heat, acid, and time degrade the active, formulators add an overage on top of the label claim so the piece still tests at full potency at the end of shelf life. That overage is the most expensive material in the formula, milligram for milligram. Tight dose control protects the label and the margin.
Regulatory Status and Required Documentation
NMN's regulatory status has moved twice in four years. In late 2022, the FDA excluded NMN from the dietary supplement definition under the drug preclusion clause, because the ingredient had been authorized for investigation as a new drug. The agency reversed that decision on September 29, 2025, after reviewing evidence that NMN had been sold as a supplement as early as 2017, before the drug investigation was authorized. In two letters that day, the FDA confirmed NMN is not excluded and may be marketed as a dietary supplement. In December 2025, it sent letters reinstating NDI status for NMN suppliers including SyncoZymes and Inner Mongolia Kingdomway.
NR never had this problem. It holds GRAS status and an accepted new dietary ingredient notification, and it has been sold in the U.S. without interruption.
The NMN question is settled for now, but the drug preclusion analysis remains open to legal challenge, and a future administration could revisit it. Brands that keep full documentation will be positioned either way.
KorNutra handles this by:
- Maintaining full chain of custody from raw material to finished good
- Third-party testing for degradation products like nicotinamide and ribose
- Documenting every temperature, pH, and time point in master manufacturing records
- Operating under full cGMP compliance per 21 CFR Part 111
What This Means for Your Brand
If you're considering an NAD+ gummy, you need a manufacturing partner who understands thermal stability, taste masking, dose uniformity, and regulatory nuance. Many contract manufacturers will say "yes" to anything, then struggle through production and deliver a product that degrades on the shelf or fails potency tests.
KorNutra spent years mastering this specific formulation. We solve the problems other manufacturers avoid.
A stable NAD+ gummy depends on process control as much as the formula. Choose a partner who treats it that way.
Ready to talk about your NAD+ gummy project? Contact KorNutra for stability data, taste trials, and regulatory strategy.